Envita Medical Centers
Envita Medical Centers in Scottsdale, Arizona, specializes in personalized, integrative treatments for cancer and chronic diseases, utilizing advanced genetic testing, immunology, transcriptomics, and innovative therapies such as genetically targeted fractionated chemotherapy (GTFC). With over two decades of research and clinical experience, Envita combines natural therapies with conventional medicine to provide hope and effective solutions for complex and resistant cases. The center is pioneering advanced immunotherapy options and genetically targeted treatments, emphasizing personalized, results-oriented treatment plans that go beyond standard protocols. Envita's approach includes detailed genomic analysis, precision-targeted therapies, addressing root causes like infections, toxins, and inflammation, and considering environmental and lifestyle factors to improve outcomes and quality of life.
Industries
Nr. of Employees
medium (51-250)
Envita Medical Centers
8759 E Bell Road, Building G, Scottsdale, Arizona 85260
Products
Research-stage NGS tumor and pathogen sequencing assay
Next-generation sequencing assay under development for expanded detection and quantification of tumor-derived and pathogen nucleic acids to inform complex diagnostic and treatment decisions.
Precision treatment recommendation software
Decision-support software integrating multi-omic and clinical data to prioritize individualized therapeutic options and combinations for clinical teams.
Genetically informed fractionated chemotherapy protocol framework
Clinical protocol framework for selecting, fractionating and dosing chemotherapy regimens based on current molecular profiling and patient pharmacogenomics.
Research-stage NGS tumor and pathogen sequencing assay
Next-generation sequencing assay under development for expanded detection and quantification of tumor-derived and pathogen nucleic acids to inform complex diagnostic and treatment decisions.
Precision treatment recommendation software
Decision-support software integrating multi-omic and clinical data to prioritize individualized therapeutic options and combinations for clinical teams.
Genetically informed fractionated chemotherapy protocol framework
Clinical protocol framework for selecting, fractionating and dosing chemotherapy regimens based on current molecular profiling and patient pharmacogenomics.
Services
Individualized cancer treatment planning combining multi-omic and immunologic profiling to select targeted therapies, dosing and delivery strategies.
Integration of genomic, transcriptomic, functional and clinical data to generate prioritized, reproducible therapy recommendations for clinical teams.
Program that selects and administers low-dose, fractionated chemotherapy regimens guided by current molecular profiling and pharmacogenomic markers.
Interventional radiology procedures for direct delivery of therapeutics into tumors and targeted intra-arterial microcatheter delivery to increase local drug concentration and enable localized ablation.
Laboratory services including NGS-based tumor and pathogen assays, liquid biopsy, exosomal miRNA analysis, CTC enumeration and functional tests to inform treatment protocols.
Design and administration of combination immunotherapy approaches including adoptive cellular therapies, vaccines, checkpoint inhibitors and adjunct immune modulators tailored to tumor and immune profiles.
Individualized cancer treatment planning combining multi-omic and immunologic profiling to select targeted therapies, dosing and delivery strategies.
Integration of genomic, transcriptomic, functional and clinical data to generate prioritized, reproducible therapy recommendations for clinical teams.
Program that selects and administers low-dose, fractionated chemotherapy regimens guided by current molecular profiling and pharmacogenomic markers.
Interventional radiology procedures for direct delivery of therapeutics into tumors and targeted intra-arterial microcatheter delivery to increase local drug concentration and enable localized ablation.
Laboratory services including NGS-based tumor and pathogen assays, liquid biopsy, exosomal miRNA analysis, CTC enumeration and functional tests to inform treatment protocols.
Design and administration of combination immunotherapy approaches including adoptive cellular therapies, vaccines, checkpoint inhibitors and adjunct immune modulators tailored to tumor and immune profiles.
Expertise Areas
- Precision oncology and individualized treatment planning
- Multi-omic biomarker-driven molecular diagnostics
- Clinical bioinformatics and decision-support systems
- Pharmacogenomics and personalized dosing
Key Technologies
- Next-generation sequencing (NGS)
- Whole-transcriptome sequencing (RNA-seq)
- Liquid biopsy (circulating tumor DNA) assays
- Exosomal microRNA analysis